These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27979310)

  • 21. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.
    Ensor CM; Holtsberg FW; Bomalaski JS; Clark MA
    Cancer Res; 2002 Oct; 62(19):5443-50. PubMed ID: 12359751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.
    Delage B; Fennell DA; Nicholson L; McNeish I; Lemoine NR; Crook T; Szlosarek PW
    Int J Cancer; 2010 Jun; 126(12):2762-72. PubMed ID: 20104527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.
    Nicholson LJ; Smith PR; Hiller L; Szlosarek PW; Kimberley C; Sehouli J; Koensgen D; Mustea A; Schmid P; Crook T
    Int J Cancer; 2009 Sep; 125(6):1454-63. PubMed ID: 19533750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular arginine-dependent translation sensor reveals the dynamics of arginine starvation response and resistance in ASS1-negative cells.
    Rogers LC; Zhou J; Baker A; Schutt CR; Panda PK; Van Tine BA
    Cancer Metab; 2021 Jan; 9(1):4. PubMed ID: 33478587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells.
    Qiu F; Chen YR; Liu X; Chu CY; Shen LJ; Xu J; Gaur S; Forman HJ; Zhang H; Zheng S; Yen Y; Huang J; Kung HJ; Ann DK
    Sci Signal; 2014 Apr; 7(319):ra31. PubMed ID: 24692592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges.
    Phillips MM; Sheaff MT; Szlosarek PW
    Cancer Res Treat; 2013 Dec; 45(4):251-62. PubMed ID: 24453997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance.
    Kim Y; Kobayashi E; Kubota D; Suehara Y; Mukaihara K; Akaike K; Ito A; Kaneko K; Chuman H; Kawai A; Kitano S
    Oncotarget; 2016 Oct; 7(43):70832-70844. PubMed ID: 27683125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidis.
    Wang M; Basu A; Palm T; Hua J; Youngster S; Hwang L; Liu HC; Li X; Peng P; Zhang Y; Zhao H; Zhang Z; Longley C; Mehlig M; Borowski V; Sai P; Viswanathan M; Jang E; Petti G; Liu S; Yang K; Filpula D
    Bioconjug Chem; 2006; 17(6):1447-59. PubMed ID: 17105223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines.
    Shan YS; Hsu HP; Lai MD; Yen MC; Chen WC; Fang JH; Weng TY; Chen YL
    Sci Rep; 2015 Apr; 5():9783. PubMed ID: 25928182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy.
    Long Y; Tsai WB; Wang D; Hawke DH; Savaraj N; Feun LG; Hung MC; Chen HH; Kuo MT
    Cancer Lett; 2017 Mar; 388():54-63. PubMed ID: 27913198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel combination therapy of arginine deiminase and an arginase inhibitor targeting arginine metabolism in the tumor and immune microenvironment.
    Ye PH; Li CY; Cheng HY; Anuraga G; Wang CY; Chen FW; Yang SJ; Lee KT; Chang KY; Lai MD
    Am J Cancer Res; 2023; 13(5):1952-1969. PubMed ID: 37293150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1.
    Locke M; Ghazaly E; Freitas MO; Mitsinga M; Lattanzio L; Lo Nigro C; Nagano A; Wang J; Chelala C; Szlosarek P; Martin SA
    Cell Rep; 2016 Aug; 16(6):1604-1613. PubMed ID: 27452468
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Chu YD; Liu HF; Chen YC; Chou CH; Yeh CT
    Front Oncol; 2022; 12():996820. PubMed ID: 36530994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy.
    Carpentier J; Pavlyk I; Mukherjee U; Hall PE; Szlosarek PW
    Lung Cancer (Auckl); 2022; 13():53-66. PubMed ID: 36091646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective extracellular arginine deprivation by a single injection of cellular non-uptake arginine deiminase nanocapsules for sustained tumor inhibition.
    Qi H; Wang Y; Yuan X; Li P; Yang L
    Nanoscale; 2020 Dec; 12(47):24030-24043. PubMed ID: 33291128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism.
    Yeon A; You S; Kim M; Gupta A; Park MH; Weisenberger DJ; Liang G; Kim J
    Theranostics; 2018; 8(16):4520-4534. PubMed ID: 30214636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Argininosuccinate Synthase 1-Deficiency Enhances the Cell Sensitivity to Arginine through Decreased DEPTOR Expression in Endometrial Cancer.
    Ohshima K; Nojima S; Tahara S; Kurashige M; Hori Y; Hagiwara K; Okuzaki D; Oki S; Wada N; Ikeda JI; Kanai Y; Morii E
    Sci Rep; 2017 Mar; 7():45504. PubMed ID: 28358054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI-PEG20 treatment in CCA cell lines.
    Roeksomtawin S; Navasumrit P; Waraprasit S; Parnlob V; Sricharunrat T; Bhudhisawasdi V; Savaraj N; Ruchirawat M
    Oncol Lett; 2018 Aug; 16(2):1529-1538. PubMed ID: 30008833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The strain-dependent cytostatic activity of Lactococcus lactis on CRC cell lines is mediated through the release of arginine deiminase.
    Jastrząb R; Tomecki R; Jurkiewicz A; Graczyk D; Szczepankowska AK; Mytych J; Wolman D; Siedlecki P
    Microb Cell Fact; 2024 Mar; 23(1):82. PubMed ID: 38481270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate and adaptive resistance mechanisms to arginine deprivation therapies in sarcoma and other cancers.
    Rogers LC; Van Tine BA
    Cancer Drug Resist; 2019; 2(3):516-526. PubMed ID: 35582579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.